{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 3, Randomized Study to Compare the Efficacy and Safety of Nemtabrutinib\nVersus Ibrutinib as 1L+ Therapy in Participants with Chronic Lymphocytic Leukemia\/Small Lymphocytic\nLymphoma (BELLWAVE-011)","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-3-randomized-study-to-compare-the-efficacy-and-safety-of-nemtabrutinibversus-ibrutinib-as-1l-therapy-in-participants-with-chronic-lymphocytic-leukemia-small-lymphocyticlymphoma-bellwave-0\/#breadcrumbitem"}]}